Home from space, the crew of the Artemis II stops by the Squawk set. Commander Reid Wiseman, Pilot Victor Glover, and Mission Specialists Christina Koch and Jeremy Hansen discuss their brave journey around the moon, the newest frontiers, the emotional and physical toll of takeoff and reentry, and handling snafus–like smoke alarms and toilet troubles–while in space. Eli Lilly CEO David Ricks discusses the drugmaker’s big financial quarter in an exclusive interview. He shares the first prescription numbers of Lilly’s newest GLP-1 pill, Foundayo, as well as how it differs from Zepbound and Novo Nordisk’s Wegovy. Plus, Anthropic is in talks to raise funds at a $900B valuation, the Saudi Public Investment Fund will stop funding the LIV Golf League, and Jerome Powell will remain on the Fed’s Board of Governors after his time as Chairman ends.

Steve Liesman - 3:17

Angelica Peebles & David Ricks - 17:12

Artemis II Crew - 32:06

In this episode:

Artemis Crew, @NASAArtemis

Steve Liesman, @steveliesman

Angelica Peebles, @angelicapeebles

Joe Kernen, @JoeSquawk

Andrew Ross Sorkin, @andrewrsorkin

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

“Just So Grateful.” Artemis II Crew & Eli Lilly’s New GLP-1 Pill 4/30/26

Squawk Pod